KFU. Card publication. Novel molecular mechanisms affecting sensitivity of imatinib (IM)-resistant gastrointestinal stromal tumors to the topoisomerase type II inhibitors

- RUS
- 中文
- ES

NOVEL MOLECULAR MECHANISMS AFFECTING SENSITIVITY OF IMATINIB (IM)-RESISTANT GASTROINTESTINAL STROMAL TUMORS TO THE TOPOISOMERASE TYPE II INHIBITORS

Form of presentation

Conference proceedings in international journals and collections

Year of publication

2018

��

��

Authors, employees of KFU

Garanina Ekaterina Evgenevna, author

Bibliographic description in the original language

Garanina E.E. Novel molecular mechanisms affecting sensitivity of imatinib (IM)-resistant gastrointestinal stromal tumors to the topoisomerase type II inhibitors / E.E. Garanina, S. Boichuk; A. Galembikova; P. Dunaev; S. Khaiboullina // Euroropean Journal of Clinical Investigation. - 2018. - Vol.48, supp.1. - P.160-161

Annotation

European Journal of Clinical investigation

Keywords

gastrointestinal tumor, imatinib

The name of the journal

European Journal of Clinical investigation

Please use this ID to quote from or refer to the card

https://repository.kpfu.ru/eng/?p_id=182570&p_lang=2

Full metadata record

Field DC	Value	Language
dc.contributor.author	Garanina Ekaterina Evgenevna	ru_RU
dc.date.accessioned	2018-01-01T00:00:00Z	ru_RU
dc.date.available	2018-01-01T00:00:00Z	ru_RU
dc.date.issued	2018	ru_RU
dc.identifier.citation	Garanina E.E. Novel molecular mechanisms affecting sensitivity of imatinib (IM)-resistant gastrointestinal stromal tumors to the topoisomerase type II inhibitors / E.E. Garanina, S. Boichuk; A. Galembikova; P. Dunaev; S. Khaiboullina // Euroropean Journal of Clinical Investigation. - 2018. - Vol.48, supp.1. - P.160-161	ru_RU
dc.identifier.uri	https://repository.kpfu.ru/eng/?p_id=182570&p_lang=2	ru_RU
dc.description.abstract	European Journal of Clinical investigation	ru_RU
dc.language.iso	ru	ru_RU
dc.subject	gastrointestinal tumor	ru_RU
dc.subject	imatinib	ru_RU
dc.title	Novel molecular mechanisms affecting sensitivity of imatinib (IM)-resistant gastrointestinal stromal tumors to the topoisomerase type II inhibitors	ru_RU
dc.type	Conference proceedings in international journals and collections	ru_RU